LARRY AGUIRRE: Open Payments
NPI 1093076416 · UKIAH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 14 payments from 6 companies in 2025. Trend: 2023 $293 · 2024 $500 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| ABBVIE INC. | 1 | $17 |
| Alkermes, Inc. | 1 | $15 |
Products named: REXULTI, INVEGA SUSTENNA, UZEDY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, VRAYLAR, ARISTADA.
Industry payments across CA — which companies pay providers there.
